Deals & Cases

Schellenberg Wittmer advises Kinarus in Transaction Agreement with Perfect Holding


Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral, respiratory and ophthalmic diseases, signed a Transaction Agreement with SIX-listed Perfect Holding regarding Perfect Holding's planned acquisition of Kinarus by way of a share exchange.

The closing of the transaction is subject to the fulfilment of specific conditions, including the approval by SIX Swiss Exchange of the listing of the new shares to be issued to the shareholders of Kinarus, and the approval of the envisaged transaction by the shareholders of both companies.

Schellenberg Wittmer advises Kinarus in this transaction. The team consists of Oliver Triebold, Marcel Jakob, Nicolas Kurz, Laura Roth, Irisi Arifi (all Corporate/M&A), Michael Nordin, Roland Wild (all Tax), Olivier Favre, Fabio Elsener, Dominic Wälchli, Daniel Reinger (all Banking & Finance), Lorenza Ferrari Hofer, Dimitry Bölsterli (IP/Life Sciences).


Stay up to date!

*Required fields

Newsletters & Newsflashes

Monthly selected key topics from our practice areas, sectors and industries, plus newsflashes on recent developments.


Monthly email with the latest updates and summaries of the Swiss Federal Supreme Court's case law in arbitration matters.
Regular insights into Swiss and international trends and legal developments in the construction industry.
Regular insights and updates on key developments in the rapidly changing landscape of Environmental, Social and Corporate Governance disputes.
Concise analysis of key trends in the fast-moving world of corporate governance for board members of Swiss companies.
A regular look from a unique M&A perspective at legal changes, economic developments and societal trends in Switzerland.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.